MDMA on track for 2023 approval as PTSD therapy, says developerA medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp Share XMDMA on track for 2023 approval as PTSD therapy, says developerhttps://pharmaphorum.com/news/mdma-on-track-for-2023-approval-as-ptsd-therapy-says-developer/
Evidence builds for use of MDMA as PTSD therapyMDMA has become notorious as an illegal dance drug – but the evidence supporting its approval as a treatment for post-traumatic Share XEvidence builds for use of MDMA as PTSD therapyhttps://pharmaphorum.com/news/evidence-builds-for-use-of-mdma-as-ptsd-therapy/
